We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$11.2B
AUM Growth
-$925M
Cap. Flow
-$880M
Cap. Flow %
-7.89%
Top 10 Hldgs %
15.04%
Holding
603
New
165
Increased
118
Reduced
122
Closed
159

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$155M
2
NXPI icon
NXP Semiconductors
NXPI
+$138M
3
CRM icon
Salesforce
CRM
+$124M
4
AKAM icon
Akamai
AKAM
+$114M
5
PF
Pinnacle Foods, Inc.
PF
+$113M

Sector Composition

Rank Sector Weight
1 Technology 18.82%
2 Industrials 16.36%
3 Energy 11.6%
4 Financials 11.57%
5 Healthcare 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EAF icon
301
GrafTech
EAF
$212M
$3.6M 0.03%
+20,000
New +$3.65M
CLVS
302
DELISTED
Clovis Oncology, Inc.
CLVS
$3.52M 0.03%
+77,478
New +$3.77M
MOR
303
DELISTED
MorphoSys AG American Depositary Shares
MOR
$3.45M 0.03%
+113,620
New +$3.12M
LECO icon
304
Lincoln Electric
LECO
$15.4B
$3.42M 0.03%
39,007
+880
+2% +$78.4K
LINC icon
305
Lincoln Educational Services
LINC
$1.3B
$3.38M 0.03%
1,939,494
+62,018
+3% +$115K
AUTL
306
Autolus Therapeutics
AUTL
$562M
$3.35M 0.03%
+125,000
New +$3.3M
RYTM icon
307
Rhythm Pharmaceuticals
RYTM
$7.96B
$3.35M 0.03%
+107,107
New +$2.93M
STZ icon
308
Constellation Brands
STZ
$23.2B
$3.3M 0.03%
+15,057
New +$3.4M
BV icon
309
BrightView Holdings
BV
$1.07B
$3.29M 0.03%
+150,000
New +$3.25M
HON icon
310
Honeywell
HON
$78B
$3.27M 0.03%
+25,155
New +$3.35M
MLNT
311
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$3.17M 0.03%
+100,000
New +$3.6M
IVTY
312
DELISTED
Invuity, Inc
IVTY
$3.16M 0.03%
810,629
-89,371
-10% -$310K
P
313
Everpure Inc
P
$29.9B
$3.11M 0.03%
130,365
-648,955
-83% -$14.3M
ESV
314
DELISTED
Ensco Rowan plc
ESV
$3.07M 0.03%
+105,712
New +$2.59M
SPR
315
DELISTED
Spirit AeroSystems
SPR
$3.07M 0.03%
+35,696
New +$3M
NRCG
316
DELISTED
NRC Group Holdings Corp.
NRCG
$3.04M 0.03%
300,000
MXIM
317
DELISTED
Maxim Integrated Products
MXIM
$3.04M 0.03%
+51,836
New +$3.02M
APTX
318
DELISTED
Aptinyx Inc. Common Stock
APTX
$3.02M 0.03%
+125,000
New +$2.68M
CMTA
319
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$2.97M 0.03%
225,862
+56,192
+33% +$910K
HUNT
320
CALL
DELISTED
Hunter Maritime Acquisition Corp. Common Stock
HUNT
$2.96M 0.03%
300,000
SPGI icon
321
S&P Global
SPGI
$120B
$2.96M 0.03%
+14,519
New +$2.87M
FN icon
322
Fabrinet
FN
$20.1B
$2.95M 0.03%
80,041
-402,170
-83% -$13.8M
SURF
323
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$2.95M 0.03%
+180,781
New +$2.62M
AMRX icon
324
Amneal Pharmaceuticals
AMRX
$5.79B
$2.91M 0.03%
+177,440
New +$3.11M
HUBS icon
325
HubSpot
HUBS
$10.5B
$2.89M 0.03%
+23,062
New +$2.73M

Similar funds

Alyeska Investment Group's Q2 2018 Portfolio in Review

As of Q2 2018, Alyeska Investment Group held 603 positions worth $11.2B, down 7.7% from $12.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Alyeska Investment Group withdrew a net $880M in Q2 2018, closing 159 positions and reducing 122 holdings. Its most notable exit was IBM, an estimated $155M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Energy.

Against the trend, Alyeska Investment Group opened a new position in Skyworks Solutions worth $122M.

  • Alyeska Investment Group's largest Q2 2018 buy was Skyworks Solutions: 1,261,692 shares worth $122M.
  • Alyeska Investment Group added most to Alphabet (Google) Class A in Q2 2018, an estimated $142M increase.
  • Alyeska Investment Group's biggest Q2 2018 reduction was Salesforce, cutting an estimated $124M.
  • Alyeska Investment Group fully exited IBM in Q2 2018, selling an estimated $155M.
  • Alyeska Investment Group's ten largest holdings make up 15% of its $11.2B portfolio in Q2 2018.
  • Alyeska Investment Group opened 165 new positions and closed 159 in Q2 2018.
  • Alyeska Investment Group's portfolio value fell 7.7% quarter-over-quarter to $11.2B.

Based on Alyeska Investment Group's 13F filing for Q2 2018, filed 14 Aug 2018.